| 000 | 00000nam##2200000za#4500 |
| 001 | 9.552518 |
| 003 | CaOODSP |
| 005 | 20231123084322 |
| 007 | ta |
| 008 | 150406|2006||||xxc||||| f|0| 0 eng|d |
| 020 | |a978-0-660-66003-5 |
| 022 | |a0317-2376 |
| 040 | |aCaOODSP|beng |
| 041 | |aeng |
| 041 | |afre |
| 043 | |an-cn--- |
| 086 | 1 |aFR4-2006/2 |
| 110 | 1 |aCanada. |bForeign Affairs and International Trade Canada. |
| 245 | 10|aConformity assessment : |bMutual Recognition Agreement on Conformity Assessment in relation to Medicines Good Manufacturing Practice Inspection and Certification between the Government of Canada and the Government of Australia, Canberra, 16 March 2005, in force 1 January 2006 |
| 260 | |aOttawa - Ontario : |bForeign Affairs and International Trade |cc2010. |
| 300 | |a45p. ; |c25 cm. |
| 490 | 1 |aTreaty series|x0317-2376|v2006/2 |
| 563 | |aSoftcover |
| 590 | |a10-35|b2010-09-03 |
| 690 | 07|aDrugs|2gcpds |
| 690 | 07|aCertification|2gcpds |
| 690 | 07|aInspection|2gcpds |
| 792 | |tÉvaluation de la conformité : |efre|w(CaOODSP)9.552519 |
| 830 | #0|aTreaty series,|x0317-2376|v2006/2|w(CaOODSP)9.509228 |